Opus Genetics, Inc.
Opus Genetics, Inc. (IRD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IRD · as of Jun 9, 2026
Key Statistics
Explore Opus Genetics, Inc. Data
ird stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 100.0%
The IRD analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $8.67, representing +115.14% upside from the current price of $4.03.
Competitors & Peers
ird competitorsIRD
ABOS
AGEN
ALEC
CGTX
HURAStock Performance
Full HistoryAbout Opus Genetics, Inc.
Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unme…
what is opus genetics, inc. · ird stock overview · opus genetics, inc. company profile · who is opus genetics, inc. ceo · ird NASDAQ · opus genetics, inc. headquarters · opus genetics, inc. business segments
About Stock Overview & Key Data
Opus Genetics, Inc. (IRD) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 19, 2015. As of the latest trading session, IRD stock price is $4.03, with a market capitalization of $328.0M. The stock has returned +283.81% over the past 12 months and +100.50% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Opus Genetics, Inc. stock is Buy, with an average 12-month price target of $8.67. In fiscal year 2025, Opus Genetics, Inc. reported revenue of $14.2M and net income of -$49.6M. For detailed data — including Opus Genetics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Opus Genetics, Inc. (IRD) stock price is $4.03. The stock is traded on NASDAQ under the ticker symbol IRD. The 52-week range is $0.90 – $5.81.